MISSION: Syracuse Biolabs aims to become a premiere Central New York laboratory focused on facilitating commercial development of early stage biochemical based technologies, including but not limited to, diagnostics, biosensing, therapeutics and medical technology.
OVERVIEW: Syracuse Biolabs is a for-profit S corporation focused on meeting its corporate mission by partnering with academic and start-up laboratories and leveraging federal funding mechanisms to drive novel biotechnologies from early stage funding through commercialization. Syracuse Biolabs founder, Dr. Mark McPike, has 11+ years preparing SBIR-STTR applications and leading funded Phase I and II SBIR-STTR projects as Principal Investigator (PI) and Co-PI. Dr. McPike has led projects from NIH, AFRL, HSARPA, and DOD. Syracuse Biolabs provides:
- An avenue for ambitious academic researchers and start-up laboratories to streamline the SBIR-STTR application process.
- Access to independent laboratory space dedicated to technology commercialization (a critical requirement for the SBIR-STTR funding mechanism).
- A flexible business, accounting and payroll infrastructure that supports SBIR-STTR projects.
- A business development support team for technology transition (i.e. spin-off company, sub license) or internal product development, sales and marketing.
PRESIDENT: Dr. Mark McPike, Ph.D.